TY - JOUR
T1 - Plasma sublimation for the treatment of xanthelasma palpebrarum
AU - Rubins, Silvestrs
AU - Ritina, Ingrida
AU - Jakus, Jeannette
AU - Rubins, Andris
N1 - Publisher Copyright:
© 2020, Slovenian Medical Society. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Introduction: Xanthelasma palpebrarum (XP) is a common xanthomatous lesion of the eyelid and periorbital skin. Several methods of treatment have been reported in the literature, each having its own indications and risks. We present a new treatment method for removing XP using a plasma exeresis device (Plexr®, GMV, Italy). Methods: Fifteen patients with a total of 27 treated XPs were assessed and clinically identified by the treating dermatologist. Patients were photographed and assessed by a dermatologist prior to and immediately after treatment. A patient survey was conducted 12 months after the procedure, which assessed the outcome of the procedure (redness, pigmentation disorders, and scars). Results: After just a single treatment session using a plasma sublimation, all 27 XPs showed complete clearance. There were no reports of scars, pigmentary alteration, or recurrence of lesions up to 12 months. Conclusions: We present plasma sublimation as a new method for the treatment of XP. During the procedure, the method allows to control the depth of tissue destruction and the presence of xanthoma tissue, and to minimize pain and trauma, making it particu-larly ideal for treating areas around the eye.
AB - Introduction: Xanthelasma palpebrarum (XP) is a common xanthomatous lesion of the eyelid and periorbital skin. Several methods of treatment have been reported in the literature, each having its own indications and risks. We present a new treatment method for removing XP using a plasma exeresis device (Plexr®, GMV, Italy). Methods: Fifteen patients with a total of 27 treated XPs were assessed and clinically identified by the treating dermatologist. Patients were photographed and assessed by a dermatologist prior to and immediately after treatment. A patient survey was conducted 12 months after the procedure, which assessed the outcome of the procedure (redness, pigmentation disorders, and scars). Results: After just a single treatment session using a plasma sublimation, all 27 XPs showed complete clearance. There were no reports of scars, pigmentary alteration, or recurrence of lesions up to 12 months. Conclusions: We present plasma sublimation as a new method for the treatment of XP. During the procedure, the method allows to control the depth of tissue destruction and the presence of xanthoma tissue, and to minimize pain and trauma, making it particu-larly ideal for treating areas around the eye.
KW - Aesthetic medicine
KW - Plasma sublimation
KW - Xanthelasma palpebrarum
UR - https://www.scopus.com/pages/publications/85086863386
U2 - 10.15570/actaapa.2020.13
DO - 10.15570/actaapa.2020.13
M3 - Article
C2 - 32566950
AN - SCOPUS:85086863386
SN - 1318-4458
VL - 29
SP - 55
EP - 57
JO - Acta Dermatovenerologica Alpina, Pannonica et Adriatica
JF - Acta Dermatovenerologica Alpina, Pannonica et Adriatica
IS - 2
ER -